ofloxacin has been researched along with Influenza, Human in 2 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Influenza, Human: An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Significant associations between levofloxacin use and influenza rates, after accounting for season, may suggest that levofloxacin was used to treat secondary bacterial infections or was prescribed inappropriately for seasonal viral respiratory tract infections." | 3.76 | A province-level risk factor analysis of fluoroquinolone consumption patterns in Canada (2000-06). ( Finley, R; Glass, SK; McEwen, SA; Pearl, DL, 2010) |
| "The first case of 2009 pandemic influenza A (H1N1) virus infection in China was documented on May 10." | 1.35 | Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. ( Cao, B; Chen, YS; Gu, L; Li, XW; Liang, L; Liang, ZA; Lu, HZ; Lu, LH; Mao, Y; Wang, C; Wang, DY; Wang, J; Zhang, B; Zhang, SJ, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, B | 1 |
| Li, XW | 1 |
| Mao, Y | 1 |
| Wang, J | 1 |
| Lu, HZ | 1 |
| Chen, YS | 1 |
| Liang, ZA | 1 |
| Liang, L | 1 |
| Zhang, SJ | 1 |
| Zhang, B | 1 |
| Gu, L | 1 |
| Lu, LH | 1 |
| Wang, DY | 1 |
| Wang, C | 1 |
| Glass, SK | 1 |
| Pearl, DL | 1 |
| McEwen, SA | 1 |
| Finley, R | 1 |
2 other studies available for ofloxacin and Influenza, Human
| Article | Year |
|---|---|
Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Child; Child, Presch | 2009 |
A province-level risk factor analysis of fluoroquinolone consumption patterns in Canada (2000-06).
Topics: Anti-Bacterial Agents; Canada; Ciprofloxacin; Drug Utilization; Fluoroquinolones; Humans; Influenza, | 2010 |